Beer Stock Ripe for a Bearish Options Trade

Underperforming STZ stock is at risk for downgrades and price-target cuts

by Research Dept.

Published on Dec 4, 2018 at 10:23 AM

Back in October amid the broad-market sell-off, beer maker Constellation Brands, Inc. (NYSE:STZ) broke below a trendline that had supported its rise since 2012. The stock was swiftly rejected after rallying back to this trendline earlier this month, and the $200 area -- site of the August lows -- has also emerged as resistance. Now down more than 14% in 2018, it's time to make a bearish play on STZ.

181130 WKALT STZ

 

Analysts remain in the bullish camp, for now. Of the 15 brokerages covering the stock, 11 rate it a "buy" or "strong buy," while its consensus 12-month price target sits at a frothy $247.68. This indicates downgrades and/or price-target reductions are a real possibility and could push the stock lower.

You also can't count on any short-covering potential from STZ. Short interest fell by 25% in the most recent reporting period, and the 3.55 million shares sold short represents a meager 2.25% of the stock's total available float, and only 1.71 times the average daily trading volume.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this STZ commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters. Learn more about why Weekend Trader is one of our most popular options trading services.

From Schaeffer's Pro Traders
Trade Weekly Options Like a Pro

Direct from our Schaeffer's traders, your FREE guide to profiting with weeklies!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Cannabis Up-and-Comer Focuses on Streamlined Growth
This early-staged CBD stock may be setting up investors for big gains.
Drug Stock Doubles on Trial Update
ETON is another name making a big move in the healthcare space
Wall Street Dishes Out "Sell" Ratings on Healthcare Stocks
Multiple bear notes have hit the healthcare sector today
Cannabis Up-and-Comer Focuses on Streamlined Growth
This early-staged CBD stock may be setting up investors for big gains.